Clinical trials go-ahead for ‘green’ medical device propellant

Sameer Bharadwaj
A Cheshire medical group has been given approval by US authorities to proceed with trials for its 'green' technology used in devices such as asthma inhalers.Koura, previously known as Mexichem Fluor, has been developing its Zephex 152a technology for several years.It enables more than than a 90% reduction in inhaler carbon footprints compared with current metered-dose inhalers (MDIs).Zephex has now been given FDA approval to proceed to clinical trials.“Koura has a proud history of innovation, and these forthcoming cl... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...
Close